Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.

Arteaga CL, Baselga J
Clin Cancer Res. 2003 9 (5): 1579-89

PMID: 12738709

MeSH Terms (9)

Antineoplastic Agents Clinical Trials as Topic Disease Management Drug Delivery Systems ErbB Receptors Humans Neoplasms Research Design Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: